Flavone compounds for the treatment and prophylaxis of hepatitis B virus disease
US-12012390-B2 · Jun 18, 2024 · US
Benzothiopyrans; Hydrogenated benzothiopyrans
Benzothiopyrans; Hydrogenated benzothiopyrans · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07D335/06 |
| Official title | Benzothiopyrans; Hydrogenated benzothiopyrans |
| Display label | Benzothiopyrans; Hydrogenated benzothiopyrans |
| Total patents | 64 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is rapidly declining.
| Year | Patents |
|---|---|
| 2015 | 6 |
| 2016 | 6 |
| 2017 | 5 |
| 2018 | 8 |
| 2019 | 7 |
| 2020 | 10 |
| 2021 | 9 |
| 2022 | 2 |
| 2023 | 4 |
| 2024 | 6 |
| 2025 | 1 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Chromane-substituted, tetrahydroquinoline-substituted and thiochromane-substituted heteroarotinoids as anti-cancer agents
US-11993573-B2 · May 28, 2024 · US
Compounds for optically active devices
US-11958819-B2 · Apr 16, 2024 · US
Resist composition and pattern forming process
US-2023393462-A1 · Dec 7, 2023 · US
Photoactive compounds, photoresist compositions including the same, and pattern formation methods
US-2023314934-A1 · Oct 5, 2023 · US
Sox11 inhibitors for treating mantle cell lymphoma
US-2023242496-A1 · Aug 3, 2023 · US
Hydrophobic compounds for optically active devices
US-11702396-B2 · Jul 18, 2023 · US
Flavone compounds for the treatment and prophylaxis of hepatitis b virus disease
US-2022363657-A1 · Nov 17, 2022 · US
Heterocyclic antiestrogens
US-11465990-B2 · Oct 11, 2022 · US
Compounds for optically active devices
US-2021363122-A1 · Nov 25, 2021 · US
Hydrophilic compounds for optically active devices
US-11111226-B2 · Sep 7, 2021 · US
ROR-gamma modulators and uses thereof
US-11084784-B2 · Aug 10, 2021 · US
Compounds for optically active devices
US-11078177-B2 · Aug 3, 2021 · US
Chroman-substituted, tetrahydroquinoline-substituted and thiochroman-substituted heteroarotinoids as anti-cancer agents
US-2021163415-A1 · Jun 3, 2021 · US
Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same
US-11001564-B2 · May 11, 2021 · US
Compounds for optically active devices
US-11001576-B2 · May 11, 2021 · US
Chroman-substituted, tetrahydroquinoline-substituted and thiochroman-substituted heteroarotinoids as anti-cancer agents
US-10947198-B2 · Mar 16, 2021 · US
Novel heterocyclic antiestrogens
US-2021053947-A1 · Feb 25, 2021 · US
Heterocyclic antiestrogens
US-10865199-B2 · Dec 15, 2020 · US
Hydrophilic compounds for optically active devices
US-2020262805-A1 · Aug 20, 2020 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07D335/06?
- CPC C07D335/06 is the Cooperative Patent Classification code for “Benzothiopyrans; Hydrogenated benzothiopyrans.”
- How many patents are filed under CPC C07D335/06 (Benzothiopyrans; Hydrogenated benzothiopyrans)?
- Our database includes 64 publications tagged with this CPC code.
- Is patent activity under CPC C07D335/06 growing?
- Publication counts under this code: 6 in 2024 vs 1 in 2025 (latest complete years).